- Dimesna
-
- $0.00 / 1g
-
2020-07-22
- CAS:16208-51-8
- Min. Order: 1g
- Purity: 99.0%
- Supply Ability: 50kg/month
- Dimesna
-
- $0.10 / 1KG
-
2019-12-26
- CAS:16208-51-8
- Min. Order: 1KG
- Purity: 95%-99%
- Supply Ability: 1kg; 100kg; 1000kg
|
| | Dimesna Basic information |
| Product Name: | Dimesna | | Synonyms: | Disodium 2,2`-dithio-bis-ethane sulphonate;DIMESNA (DISODIUM 2,2'-DITHIOBISETHANE SULFONATE);DIMESNA(SUBJECTTOPATENTFREE);Bis(2-sulfoethyl)disulfide disodium salt;Disodium 2,2'-dithiodiethanesulfonate;2,2'-dithiobis(ethanesulfonic acid), disodium salt;2,2'-Dithiobis(ethanesulfonic acid sodium) salt;Bis(2-sulfoethyl) persulfide disodium salt | | CAS: | 16208-51-8 | | MF: | C4H8Na2O6S4 | | MW: | 326.34 | | EINECS: | 240-337-2 | | Product Categories: | Other APIs;Aliphatics;Sulfur & Selenium Compounds | | Mol File: | 16208-51-8.mol |  |
| | Dimesna Chemical Properties |
| | Dimesna Usage And Synthesis |
| Chemical Properties | White Solid | | Uses | Dimesna reacts with acrolein and other urotoxic metabolites of oxazaphosphorines (cyclophosphamide or ifosfamide) to form stable, non-urotoxic compounds. Mesna does not have any antitumour activity, nor does it appear to interfere with the antitumour activity of antineoplastic drugs. This medication is used to protect the bladder wall from the harmful effects of some cancer-fighting drugs. | | Uses | Dimesna (Mesna EP Impurity D) reacts with acrolein and other urotoxic metabolites of oxazaphosphorines (cyclophosphamide or ifosfamide) to form stable, non-urotoxic compounds. Mesna does not have any antitumour activity, nor does it appear to interfere with the antitumour activity of antineoplastic drugs. This medication is used to protect the bladder wall from the harmful effects of some cancer-fighting drugs. |
| | Dimesna Preparation Products And Raw materials |
|